Eisai has established a collaboration with Cogstate, Cognigram’s developer, to develop and commercialize digital brain performance assessment tools for individuals and health care professionals.
Our Heritage and Commitment
- Our vision: a world free of neurodegeneration
- 35+ years of pioneering drug development in Alzheimer's disease and neurology¹
- Committed to redefining brain health and bringing forward new solutions that can help earlier identify neurodegeneration
- Aspire to a future where we can prevent neurodegeneration before it starts
- Our fundamental belief: brain health is profoundly important to quality of life and should be easier to measure
- 20+ years of pioneering cognitive assessment²
- Committed to simplifying the measurement of cognition by applying our expertise, access to data and flexible technology
Through our collaboration, we are committed to advancing cognitive assessment and early detection to help improve the quality of care in brain health.
Our Mission: Human Health Care
Eisai is a company that focuses not only on developing pharmaceuticals but also the potential of corporate activities that go beyond the provision of medicines. We believe that our mission is not limited to simply delivering the drugs to the patient.
All Eisai employees give first thought to patients and the people in the daily living domain and discuss what we should do to increase the benefits that health care provides to them, from the perspective of being a customer. Then, we will put it into practice in our business activities, demonstrate it, disseminate it to the world, and change society. This is our cherished corporate concept, human health care (hhc).
Learn more